Boehringer Ingelheim GmbH’s Drug Lowers Bleeding Risk in Those Who Had Stroke

Bloomberg -- Boehringer Ingelheim GmbH’s Pradaxa blood thinner lowered the risk of major bleeding in patients taking the drug to prevent another stroke or stroke-like attack, according to a new analysis of a study.